{{Rsnum
|rsid=4243229
|Gene=HSD17B2
|Chromosome=16
|position=82051993
|Orientation=plus
|GMAF=0.08815
|Gene_s=HSD17B2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 1.8 | 98.2
| HCB | 3.6 | 29.2 | 67.2
| JPT | 7.1 | 26.5 | 66.4
| YRI | 3.4 | 22.4 | 74.1
| ASW | 0.0 | 21.1 | 78.9
| CHB | 3.6 | 29.2 | 67.2
| CHD | 2.8 | 31.2 | 66.1
| GIH | 0.0 | 11.9 | 88.1
| LWK | 0.0 | 20.0 | 80.0
| MEX | 0.0 | 5.2 | 94.8
| MKK | 1.9 | 11.5 | 86.5
| TSI | 0.0 | 2.9 | 97.1
| HapMapRevision=28
}}{{PMID Auto
|PMID=23186779
|Title=Molecular markers in Key Steroidogenic Pathways, Circulating steroid levels and Prostate Cancer progression
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}